OBJECTIVES/HYPOTHESIS: Laryngotracheal stenosis (LTS) is largely considered a structural entity, defined on anatomic terms (i.e., percent stenosis, distance from vocal folds, overall length). This has significant implications for identifying at-risk populations, devising systems-based preventive strategies, and promoting patient-centered treatment. The present study was undertaken to test the hypothesis that LTS is heterogeneous with regard to etiology, natural history, and clinical outcome. STUDY DESIGN: Retrospective cohort study of consecutive adult tracheal stenosis patients from 1998 to 2013. METHODS: Subjects diagnosed with laryngotracheal stenosis (ICD-9: 478.74, 519.19) between January 1, 1998, and January 1, 2013, were identified. Patient characteristics (age, gender, race, follow-up duration) and comorbidities were extracted. Records were reviewed for etiology of stenosis, treatment approach, and surgical dates. Stenosis morphology was derived from intraoperative measurements. The presence of tracheostomy at last follow-up was recorded. RESULTS: One hundred and fifty patients met inclusion criteria. A total of 54.7% had an iatrogenic etiology, followed by idiopathic (18.5%), autoimmune (18.5%), and traumatic (8%). Tracheostomy dependence differed based on etiology (P < 0.001). Significantly more patients with iatrogenic (66%) and autoimmune (54%) etiologies remained tracheostomy-dependent compared to traumatic (33%) or idiopathic (0%) groups. On multivariate regression analysis, each additional point on Charlson Comorbidity Index was associated with a 67% increased odds of tracheostomy dependence (odds ratio 1.67; 95% confidence interval 1.04-2.69; P = 0.04). CONCLUSIONS: Laryngotracheal stenosis is not a homogeneous clinical entity. It has multiple distinct etiologies that demonstrate disparate rates of long-term tracheostomy dependence. Understanding the mechanism of injury and contribution of comorbid illnesses is critical to systems-based preventive strategies and patient-centered treatment. LEVEL OF EVIDENCE: 4.
OBJECTIVES/HYPOTHESIS: Laryngotracheal stenosis (LTS) is largely considered a structural entity, defined on anatomic terms (i.e., percent stenosis, distance from vocal folds, overall length). This has significant implications for identifying at-risk populations, devising systems-based preventive strategies, and promoting patient-centered treatment. The present study was undertaken to test the hypothesis that LTS is heterogeneous with regard to etiology, natural history, and clinical outcome. STUDY DESIGN: Retrospective cohort study of consecutive adult tracheal stenosispatients from 1998 to 2013. METHODS: Subjects diagnosed with laryngotracheal stenosis (ICD-9: 478.74, 519.19) between January 1, 1998, and January 1, 2013, were identified. Patient characteristics (age, gender, race, follow-up duration) and comorbidities were extracted. Records were reviewed for etiology of stenosis, treatment approach, and surgical dates. Stenosis morphology was derived from intraoperative measurements. The presence of tracheostomy at last follow-up was recorded. RESULTS: One hundred and fifty patients met inclusion criteria. A total of 54.7% had an iatrogenic etiology, followed by idiopathic (18.5%), autoimmune (18.5%), and traumatic (8%). Tracheostomy dependence differed based on etiology (P < 0.001). Significantly more patients with iatrogenic (66%) and autoimmune (54%) etiologies remained tracheostomy-dependent compared to traumatic (33%) or idiopathic (0%) groups. On multivariate regression analysis, each additional point on Charlson Comorbidity Index was associated with a 67% increased odds of tracheostomy dependence (odds ratio 1.67; 95% confidence interval 1.04-2.69; P = 0.04). CONCLUSIONS:Laryngotracheal stenosis is not a homogeneous clinical entity. It has multiple distinct etiologies that demonstrate disparate rates of long-term tracheostomy dependence. Understanding the mechanism of injury and contribution of comorbid illnesses is critical to systems-based preventive strategies and patient-centered treatment. LEVEL OF EVIDENCE: 4.
Authors: I J Kleiss; A F T M Verhagen; J Honings; O C J Schuurbiers; H F M van der Heijden; H A M Marres Journal: Clin Otolaryngol Date: 2013-08 Impact factor: 2.597
Authors: A Brichet; C Verkindre; J Dupont; M L Carlier; J Darras; A Wurtz; P Ramon; C H Marquette Journal: Eur Respir J Date: 1999-04 Impact factor: 16.671
Authors: Kevin Motz; Idris Samad; Linda X Yin; Michael K Murphy; Madhavi Duvvuri; Dacheng Ding; Alexander T Hillel Journal: JAMA Otolaryngol Head Neck Surg Date: 2017-11-01 Impact factor: 6.223
Authors: Deborah X Xie; Saad C Rehman; David O Francis; James L Netterville; C Gaelyn Garrett; Alexander Gelbard; Brittany Lipscomb; Christopher T Wootten Journal: JAMA Otolaryngol Head Neck Surg Date: 2019-03-01 Impact factor: 6.223
Authors: Linda X Yin; Kevin M Motz; Idris Samad; Madhavi Duvvuri; Michael Murphy; Dacheng Ding; Alexander T Hillel Journal: Otolaryngol Head Neck Surg Date: 2017-03-28 Impact factor: 3.497
Authors: Michael K Murphy; Kevin M Motz; Dacheng Ding; Linda Yin; Madhavi Duvvuri; Michael Feeley; Alexander T Hillel Journal: Laryngoscope Date: 2017-09-20 Impact factor: 3.325
Authors: Alexander T Hillel; Selmin Karatayli-Ozgursoy; Idris Samad; Simon R A Best; Vinciya Pandian; Laureano Giraldez; Jennifer Gross; Christopher Wootten; Alexander Gelbard; Lee M Akst; Michael M Johns Journal: Ann Otol Rhinol Laryngol Date: 2015-10-14 Impact factor: 1.547
Authors: Kevin M Motz; Linda X Yin; Idris Samad; Dacheng Ding; Michael K Murphy; Madhavi Duvvuri; Alexander T Hillel Journal: Otolaryngol Head Neck Surg Date: 2017-05-09 Impact factor: 3.497
Authors: Linda X Yin; William V Padula; Shekhar Gadkaree; Kevin Motz; Sabrina Rahman; Zachary Predmore; Alexander Gelbard; Alexander T Hillel Journal: Otolaryngol Head Neck Surg Date: 2018-11-27 Impact factor: 3.497